MSH|^~\&|QLS^2.16.840.1.113883.3.165.2^ISO|QUEST WEST HILLS^05D0642827^CLIA|NV^2.16.840.1.114222.4.3.2.2.3.600.4^ISO|NVDOH^2.54.944.1.447329.0.2.400493^ISO|20220917040328.0098-0700||ORU^R01^ORU_R01|MET-ELRNV00-LV180458S-20220917-20220917 04:03:28.0098-2|P|2.5.1|||AL|AL|USA||||PHLabReport-Ack^^2.16.840.1.113883.9.11^ISOSFT|QUEST DIAGNOSTICS^L^^^^^^WD&2.16.840.1.113883.3.165.2&ISO|1.0|ANTRIM|BINARY ID UNKNOWNPID|1|replaced 14|||Milan77^Heller342||19561120|M|||405 Becker Street^^Carlin^NV^89822|US|^PRN^PH^^1^135^2979517|||||||||||||||||PV1|1|U|^ED03^ED03^^^^^ED^DESERT VIEW HOSP ALL|||||||||||||||||||||||||||||||||||||||||20220913ORC|RE|09789836G3eXM^QUEST^2.16.840.1.113883.3.165.5^ISO|LV180458S6G3eXM_395QAW^QUEST^2.16.840.1.113883.3.165.4^ISO||CM|||||||1326224056^MCGARRY^JONATHON^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^||^^^^^^|||||||DESERT VIEW HOSPITAL-CPU^D|360 S LOLA LN^^PAHRUMP^NV^89048-0884^USA^O|^WPN^PH^^1^775^7517852^^OFFICE CONTACT: BRYAN CURTIS|360 S LOLA LN^^PAHRUMP^NV^89048-0884OBR|1|09789836G3eXM^QUEST^2.16.840.1.113883.3.165.5^ISO|LV180458S6G3eXM_395QAW^QUEST^2.16.840.1.113883.3.165.4^ISO|^^^395^CULTURE, URINE, ROUTINE^L^^v unknown|||202209132200-0700|||||||||1326224056^MCGARRY^JONATHON^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^|^^^^^^|||||20220916161300-0700|||F||||||OBX|1|CE|43409-2^BACTERIA ISLT CULT^LN^75000300^ISOLATE 1:^L^^v unknown|1|409800005^Escherichia coli (ESBL)^SCT^ECESBL^Escherichia coli (ESBL)^L|||A^Abnormal (applies to non-numeric results)^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDNTE|1||ESCHERICHIA COLI (ESBL)NTE|2||GREATER THAN 100,000 CFU/ML OFNTE|3||**MULTIPLE DRUG RESISTANT ORGANISM**NTE|4||ESBL RESULT:        THE ORGANISM HAS BEEN CONFIRMED AS AN ESBL PRODUCER.SPM|1|09789836G3eXM&QUEST&2.16.840.1.113883.3.165.5&ISO^LV180458S6G3eXM&QUEST&2.16.840.1.113883.3.165.4&ISO||122575003^Urine specimen (specimen)^SCT^UR^Urine^HL70487^2.5.1^V UNKNOWN^URINE|||||||||||||202209132200-0700|20220914183300-0700OBR|2|09789836G3eXM^QUEST^2.16.840.1.113883.3.165.5^ISO|LV180458S6G3eXM_URANEG1,395QAW,75000300^QUEST^2.16.840.1.113883.3.165.4^ISO|^^^URANEG1^URA,1NEG ^L^^v unknown|||202209132200-0700|||||||||1326224056^MCGARRY^JONATHON^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^^^^^^^^|^^^^^^|||||20220916161300-0700|||F|43409-2&BACTERIA ISLT CULT&LN&75000300&ISOLATE 1:&L&&v unknown^1^Escherichia coli (ESBL)|||09789836G3eXM&QUEST&2.16.840.1.113883.3.165.5&ISO^LV180458S6G3eXM_395QAW&QUEST&2.16.840.1.113883.3.165.4&ISO||OBX|1|ST|18864-9^AMPICILLIN SUSC ISLT^LN^77000216^AMPICILLIN^L^^v unknown|1|>=32,E21|||R^Resistant. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDNTE|1||EXTENDED SPECTRUM BETA-LACTAMASE (ESBL) PRODUCINGNTE|2||ORGANISMS DEMONSTRATE DECREASED ACTIVITY WITHNTE|3||PENICILLINS, CEPHALOSPORINS AND AZTREONAM.OBX|2|SN|18865-6^AMPICILLIN+SULBAC SUSC ISLT^LN^77000316^AMP/SULBACTAM^L^^v unknown|1|>=^32|1^^L||R^Resistant. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDOBX|3|NM|18862-3^AMOXICILLIN+CLAV SUSC ISLT^LN^77000106^AMOX/CLAVULANATE^L^^v unknown|1|16|1^^L||I^Intermediate. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDOBX|4|SN|18895-3^CEFTRIAXONE SUSC ISLT^LN^77002206^CEFTRIAXONE^L^^v unknown|1|>=^64|1^^L||R^Resistant. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDOBX|5|SN|18893-8^CEFTAZIDIME SUSC ISLT^LN^77001906^CEFTAZIDIME^L^^v unknown|1|>=^64|1^^L||R^Resistant. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDOBX|6|SN|18878-9^CEFAZOLIN SUSC ISLT^LN^77000906^CEFAZOLIN^L^^v unknown|1|>=^64|1^^L||R^Resistant. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDOBX|7|SN|18906-8^CIPROFLOXACIN SUSC ISLT^LN^77002706^CIPROFLOXACIN^L^^v unknown|1|>=^4|1^^L||R^Resistant. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDOBX|8|NM|18955-5^NITROFURANTOIN SUSC ISLT^LN^77004606^NITROFURANTOIN^L^^v unknown|1|64|1^^L||I^Intermediate. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDOBX|9|SN|18879-7^CEFEPIME SUSC ISLT^LN^77002006^CEFEPIME^L^^v unknown|1|>=^64|1^^L||R^Resistant. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDOBX|10|SN|18928-2^GENTAMICIN SUSC ISLT^LN^77003706^GENTAMICIN^L^^v unknown|1|>=^16|1^^L||R^Resistant. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDOBX|11|SN|18932-4^IMIPENEM SUSC ISLT^LN^77003906^IMIPENEM^L^^v unknown|1|<=^0.25|1^^L||S^Susceptible. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDOBX|12|SN|20629-2^LEVOFLOXACIN SUSC ISLT^LN^77003306^LEVOFLOXACIN^L^^v unknown|1|>=^8|1^^L||R^Resistant. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDOBX|13|NM|18970-4^PIPERACILLIN+TAZOBAC SUSC ISLT^LN^77005456^PIP/TAZOBACTAM^L^^v unknown|1|16|1^^L||S^Susceptible. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDOBX|14|SN|18998-5^TMP SMX SUSC ISLT^LN^77006506^TRIMETHOPRIM/SULFA^L^^v unknown|1|>=^320|1^^L||R^Resistant. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDOBX|15|SN|18996-9^TOBRAMYCIN SUSC ISLT^LN^77006306^TOBRAMYCIN^L^^v unknown|1|>=^16|1^^L||R^Resistant. Indicates for microbiology susceptibilities only.^HL70078^^^^2.7|||F|||202209132200-0700|29D0652720||||20220916161242-0700||||QUEST DIAGNOSTICS - LAS VEGAS^L^^^^CLIA&2.16.840.1.113883.4.7&ISO^XX^^^29D0652720|4230 BURNHAM AVE^^LAS VEGAS^NV^89119-5408^^L|^IOLE^ELIZABETH^D.^^^^^^^^^^^^^^^^^ MDNTE|1||S=SUSCEPTIBLE  I=INTERMEDIATE  R=RESISTANT  * = NOT TESTEDNTE|2||NR = NOT REPORTED  **NN = SEE THERAPY COMMENTSSPM|1|09789836G3eXM&QUEST&2.16.840.1.113883.3.165.5&ISO^LV180458S6G3eXM&QUEST&2.16.840.1.113883.3.165.4&ISO||122575003^Urine specimen (specimen)^SCT^UR^Urine^HL70487^2.5.1^V UNKNOWN^URINE|||||||||||||202209132200-0700|20220914183300-0700
